Candel Therapeutics (CADL)

• Market cap: $295M
• 1 day: -3.58%
• 5 days: -1.82%
• 1 month: 5.49%
• 3 months: -16.59%
• 6 months: 9.57%
• Year to date: -40.16%
• 1 year: 1.89%
• 5 years: -23.14%
• 10 years: -23.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38